NASDAQ: SLGL - Sol-Gel Technologies Ltd.

Rentabilidade por seis meses: -1.3%
Rendimento de dividendos: 0.00%
Setor: Healthcare

Cronograma de promoção Sol-Gel Technologies Ltd.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel.

mais detalhes
The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; SGT-610, a rare disease for the treatment of Gorlin Syndrome which has completed Phase II clinical trials; and Erlotinib and Tapinarof to treat other rare skin indications. It is also involved in the development of generic topical dermatological drug products. The company has collaboration with Perrigo. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

IPO date 2018-01-23
ISIN IL0011417206
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.sol-gel.com
Цена ао 0.555
Alteração de preço por dia: +15.55% (0.5799)
Alteração de preço por semana: +15.53% (0.58)
Alteração de preço por mês: -17.27% (0.81)
Alteração de preço em 3 meses: +19.55% (0.5605)
Mudança de preço em seis meses: -1.3% (0.6789)
Mudança de preço por ano: -40.83% (1.1325)
Mudança de preço em 3 anos: -90.51% (7.06)
Mudança de preço em 5 anos: -94.78% (12.83)
Mudança de preço em 10 anos: 0% (0.6701)
Mudança de preço desde o início do ano: +51.98% (0.4409)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 20.92 1
P/BV 0.8411 9
P/E 0 0
EV/EBITDA -0.9182 0
Total: 4.63

Eficiência

Nome Significado Nota
ROA, % -60.15 0
ROE, % -70.48 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -0.057 10
Total: 10

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % -93.21 0
Rentabilidade Ebitda, % 15.39 3
Rentabilidade EPS, % -20.18 0
Total: 1
Mais detalhes

Instituições Volume Compartilhar, %
Phoenix Holdings Ltd. 2574922 9.24
Armistice Capital, LLC 2135000 7.66
Migdal Insurance & Financial Holdings Ltd. 1227548 4.41
Harel Insurance Investments & Financial Services Ltd. 920333 3.3
Kingdon Capital Management LLC 674923 2.42
Yelin Lapidot Holdings Management Ltd. 229178 0.82
Raymond James Financial Services Advisors, Inc. 43102 0.15
Raymond James & Associates, Inc. 30915 0.11
Morgan Stanley 28935 0.1
Citadel Advisors Llc 17259 0.06



Supervisor Cargo Pagamento Ano de nascimento
Dr. Alon Seri-Levy Co-Founder, CEO & Director 411k 1961 (64 ano)
Mr. Gilad Mamlok Advisor 367k 1968 (57 anos)
Dr. Itzik Yosef Chief Operating Officer 236k 1976 (49 anos)
Mr. Moshe Arkin Executive Chairman of the Board N/A 1953 (72 ano)
Prof. David Avnir Co-Founder N/A
Ms. Tamar Fishman Jutkowitz VP & General Counsel N/A 1976 (49 anos)
Dr. Karine Neimann VP of Projects & Planning and Chief Chemist N/A 1971 (54 ano)
Mr. Eyal Ben-Or Chief Financial Officer

Endereço: Israel, Ness Ziona, 7 Golda Meir Street - abrir no Google Maps, abrir mapas Yandex
Site: https://www.sol-gel.com